Ahmet Derya v. Sedef Gulsan

New Jersey Superior Court Appellate Division·Decided June 16, 2025·No. A-0669-23·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-0669-23

AHMET DERYA, Plaintiff-Appellant,

v. SEDEF GULSAN,

Defendant-Respondent.

Argued February 12, 2025 – Decided June 16, 2025 Before Judges Sumners and Susswein.

On appeal from the Superior Court of New Jersey, Law Division, Mercer County, Docket No. L-1265-20.

Crew Shielke argued the cause for appellant (Onal Gallant & Partners, attorneys; Crew Shielke, of counsel and on the briefs).

Paul Sheehan argued the cause for respondent (Hill Wallack, LLP, attorneys; Paul Sheehan, of counsel and on the brief).

PER CURIAM

This case arises from a partnership dispute between plaintiff Ahmet Derya and defendant Sedef Gulsan. The partnership agreement formed SG Health, LLC (SG Health) d/b/a Viva Pharmacy (Viva). After the parties sold Viva to CVS Pharmacy in 2019, plaintiff sued defendant, alleging that defendant mismanaged the business accounts, improperly took a salary in violation of their formal "Limited Liability Company Operating Agreement SG Health LLC" agreement (Operating Agreement), improperly used Viva's funds for personal use, improperly conflated her personal expenses and/or misattributed plaintiff's business expenses as personal expenses, and failed to pay plaintiff his share of the 2016 business profits.

Following a three-day trial, the jury found in defendant's favor. Plaintiff appeals from an October 6, 2023 Law Division order denying his motion for either a judgment notwithstanding the verdict (JNOV) pursuant to Rule 4:40-2, or for a new trial pursuant to Rule 4:49-1. Plaintiff also appeals from the trial court's decision awarding attorney fees and costs to defendant.

After considering the record in light of the parties' arguments and governing legal principles, we affirm most of the trial court's well-reasoned ruling upholding the jury verdict. However, defendant concedes there were two expenses that were wrongly attributed to plaintiff, one regarding approximately

A-0669-23

$6,200 for car loan payments and another for about $4,000 for car insurance payments. Although these sums are minor compared to the total damages that plaintiff1 claimed—and that the jury rejected—we are constrained to remand to the trial court to rectify the verdict with respect to these two payments. In all other respects, we affirm the trial court's ruling upholding the jury verdict. Because the two car-related payments might conceivably impact the award of attorney fees and costs, we also remand for the trial court to reconsider the fee award in light of defendant's concession regarding these payments.

I.

We presume the parties are familiar with the relevant facts and procedural history, which we need only briefly summarize. In early 2016, plaintiff purchased a forty-nine percent share of Viva from defendant in exchange for a $100,000 investment in the business. The parties did not enter into the Operating Agreement until January 2017. Pursuant to the Operating Agreement, defendant was Viva's managing member and in charge of its employees and finances. The Operating Agreement prohibited the parties from receiving salaries for their role as LLC members unless they both agreed otherwise in

1 To provide context, we note that plaintiff claimed defendant's accounting errors deprived him of approximately $420,000.

A-0669-23

writing. As a licensed pharmacist, defendant also acted as Viva's head pharmacist, a role not mentioned in the Operating Agreement. Defendant paid herself an hourly salary for her work as the head pharmacist, which plaintiff claimed was done without his knowledge and that, had he known, he would not have consented. At some point, the parties verbally agreed that plaintiff would receive weekly payments of $1,000.

The parties maintained a business bank account for Viva, which they both used for personal expenses. Plaintiff also took out three personal credit cards in the parties' names, which were used for personal and business expenses and was paid off using the business account. The parties sold Viva to CVS Pharmacy in 2019, and defendant subsequently opened a new pharmacy without plaintiff.

On July 16, 2020, plaintiff filed a six-count complaint against defendant, alleging that she mismanaged and defrauded him in managing SG Health and Viva. Plaintiff alleged, for example, that defendant withheld his fair share of profit distributions, did not maintain a proper accounting of the business, used company funds for her personal benefit, paid herself "excessive and unjustified salaries," and opened a competing pharmacy, in violation of their non-compete clause. Plaintiff further alleged that these violations constitute a breach of the duty of loyalty (count one), breach of the duty of care (count two), common law

A-0669-23

fraud (count three), unjust enrichment (count four), and breach of contract (count five), entitling him to punitive damages (count six).

On September 2, 2020, defendant moved to dismiss count three of plaintiff's complaint alleging fraud. The motion judge denied this application on September 25.

In October 2020, defendant filed a counterclaim, alleging that plaintiff failed to obtain his pharmacist license, as expected under the Operating Agreement, and did not engage in any work on behalf of the pharmacy yet still took regular distributions from the pharmacy for his personal use. Defendant alleged that this constituted a breach of contract and a violation of the New Jersey Limited Liability Company Act, N.J.S.A. 42:2C-1.

In December 2021, plaintiff filed an amended complaint to add claims of:

dissolution pursuant to N.J.S.A. 42:2C-48 (count six) 2; personal liability against defendant under N.J.S.A. 42:2C-39 (count seven); conversion (count eight); breach of implied covenant of good faith and fair dealing (count nine); promissory estoppel (count ten); tortious interference with prospective economic advantage (count eleven); and negligence (count twelve). Plaintiff

2 Plaintiff's amended complaint did not include a separate count of punitive damages, formerly count six of the initial complaint, but includes in it other requested relief.

A-0669-23

also requested that the court enter a declaratory judgment in his favor (count thirteen).

Defendant asserted thirty-five affirmative defenses, including failure to state a cause of action, the claim was time barred, doctrine of unclean hands, comparative negligence, and laches.

The jury trial was held in late July 2023. Prior to summations, plaintiff agreed to dismiss counts four (unjust enrichment), eight (conversion), ten (promissory estoppel), and twelve (negligence) based on defendant's stipulation that the Operating Agreement was a valid and operating contract. The jury returned a verdict in defendant's favor on the remaining counts.

On August 14, 2023, plaintiff moved for JNOV or, in the alternative, for a new trial pursuant to Rules 4:40-2 and 4:49-1. On August 22, defendant filed for attorney fees and costs against plaintiff. On October 6, the trial court denied plaintiff's motion for JNOV or a new trial.

On November 1, 2023, defendant filed a notice of appeal from the jury's verdict and the trial court's October 6, 2023 decision. On February 12, 2024, we temporarily remanded the matter to the trial court for a determination on defendant's fee application. Pursuant to our remand order, on March 11, the trial court granted defendant's request for attorney fees in the amount of $119,256.40.

A-0669-23

Free access — add to your briefcase to read the full text and ask questions with AI

Ahmet Derya v. Sedef Gulsan, (N.J. Ct. App. 2025).

Ahmet Derya v. Sedef Gulsan (Ahmet Derya v. Sedef Gulsan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

State v. Jarbath
555 A.2d 559 (Supreme Court of New Jersey, 1989)
Masone v. Levine
887 A.2d 1191 (New Jersey Superior Court App Division, 2005)
Faustin v. Lewis
427 A.2d 1105 (Supreme Court of New Jersey, 1981)
Fertile v. St. Michael's Medical Center
779 A.2d 1078 (Supreme Court of New Jersey, 2001)
Sons of Thunder, Inc. v. Borden, Inc.
690 A.2d 575 (Supreme Court of New Jersey, 1997)
Sun Source, Inc. v. Kuczkir
615 A.2d 1280 (New Jersey Superior Court App Division, 1992)
Rendine v. Pantzer
661 A.2d 1202 (Supreme Court of New Jersey, 1995)
Litton Industries, Inc. v. IMO Industries, Inc.
982 A.2d 420 (Supreme Court of New Jersey, 2009)
Velazquez v. Jiminez
763 A.2d 753 (New Jersey Superior Court App Division, 2000)
Packard-Bamberger & Co., Inc. v. Collier
771 A.2d 1194 (Supreme Court of New Jersey, 2001)
Kulbacki v. Sobchinsky
185 A.2d 835 (Supreme Court of New Jersey, 1962)
In Re P, and Wife
277 A.2d 566 (New Jersey Superior Court App Division, 1971)
North Bergen Rex Transport, Inc. v. Trailer Leasing Co.
730 A.2d 843 (Supreme Court of New Jersey, 1999)
Thomas v. Toys" R" US, Inc.
660 A.2d 1236 (New Jersey Superior Court App Division, 1995)
Singer v. State
472 A.2d 138 (Supreme Court of New Jersey, 1984)
Borough of Princeton v. Bd. of Chosen Freeholders of Mercer Cty.
777 A.2d 19 (Supreme Court of New Jersey, 2001)
Anderson v. AJ FRIEDMAN SUPPLY
3 A.3d 545 (New Jersey Superior Court App Division, 2010)
Risko v. Thompson Muller Automotive Group, Inc.
20 A.3d 1123 (Supreme Court of New Jersey, 2011)
Robert Smith v. Millville Rescue Squad(074685)
139 A.3d 1 (Supreme Court of New Jersey, 2016)
Andre De Garmeaux v. Dnv Concepts, Inc. T/a
151 A.3d 992 (New Jersey Superior Court App Division, 2016)